Summary: Objective: The purpose of this study was to evaluate the eŠect of atropine on the dose requirement of propofol for induction of anesthesia and propofol concentrations during continuous infusion. Methods: Study 1: Forty patients were randomly allocated to the control or atropine groups. Induction of anesthesia commenced 3 min following the administration of 0.9z saline or atropine (0.01 mg kg -1 ), using a Diprifuser set to achieve propofol concentration of 6.0 mg mL -1 . The primary end point was the propofol dose per kg at the moment of loss of response to a command. Study 2: Fifteen patients undergoing elective surgery were enrolled. Propofol was administered to all subjects via target-controlled infusion to achieve a propofol concentration at 2.0 mg mL -1 after intubation. Before and after administration of atropine (0.01 mg kg -1 ), cardiac output (CO) was measured using indocyanine green as an indicator and blood propofol concentration was determined using high-performance liquid chromatography. Results: Study 1: The propofol dose for each group was 2.22±0.21 mg kg -1 for control group and 2.45 ±0.28 mg kg -1 for atropine, respectively (p＝0.014). Study 2: After the administration of atropine, CO was signiˆcantly increased from 4.28±0.83 to 5.76±1.55 l min -1 (pº0.0001). Propofol concentration was signiˆcantly decreased from 2.12±0.28 to 1.69±0.27 mg mL -1 (pº0.0001). Conclusions: Following the administration of atropine, the propofol requirements for the induction of anesthesia were increased and propofol concentrations were decreased during continuous infusion by the administration of atropine.
Introduction
Propofol is widely used for anesthesia during surgical procedures and for the sedation of patients. Since propofol metabolism depends on liver and renal blood ‰ow, [1] [2] [3] [4] [5] it is considered that there is an important pharmacokinetic interaction between cardiac output (CO) and propofol dose requirements. It has been reported that the initial arterial concentration of propofol after short infusion was inversely related to CO in sheep. 6) Similar relationship have been reported during constant rate infusions of propofol in ovine and in swine, respectively. 7, 8) Increased CO, either druginduced or secondary to pathological states such as sepsis, may increase the doses of propofol required. An important issue is the extent to which this phenomenon could be expected to occur in human.
The administration of atropine can avoid vagus re‰ex at the induction of anesthesia or treat bradycardia during the operation. This produces the increase of cardiac output (CO) and therefore, the propofol requirements for induction of anesthesia might be increased and propofol concentrations are decreased during constant infusion by the administration of atropine. The purpose of this study was to evaluate the eŠect of atropine on the propofol dose required for induction of anesthesia and propofol concentrations during continuous infusion.
Materials and Methods

Study 1 (At the induction of anesthesia)
Subjects : After Institutional approval, informed  consent was obtained from 40 patients scheduled to  undergo open abdominal surgery (25 men and 15 women; age range, 22-64 years; weight range, 44-76 kg) and patients were randomly allocated to control group or atropine group. All patients were classiˆed as American Society of Anesthesiologists (ASA) I-II, and individuals with severe hepatic or renal insu‹ciency, coronary artery disease, signiˆcant hemodynamic instability, or known allergy to eggs or propofol were excluded from the study.
Sampling procedure: Before induction of anesthesia, routine monitoring was established, including pulse oximetry, ECG and non-invasive blood pressure. An intravenous catheter was placed in an antecubital vein for infusion of anesthetics and for ‰uid replacement.
The moment of induction of anesthesia was judged according to the criteria below. 9) Two anesthetists were involved in the study of each patient. The patient's attending anesthetist was responsible for the safety and monitoring of the patient, opening the envelope assigned to each patient and preparing and administering each drug. The second anesthetist was blind to both group allocation and physiological measurements and judged the moment of induction of anesthesia according to the criteria below. Audible tones were silenced and the monitor turned around to avoid the observer or patient being in‰uenced by physiological measurements. The patient was also blinded group allocation. No premedication was given.
The control group received 10 mL 0.9z saline intravenously followed by a 0.9z saline infusion by syringe driver. The atropine group were given 0.01 mg kg -1 of atropine, followed by an infusion of 0.9z saline. Three min after the administration of the drug, anesthesia induction was carried out with propofol and neuromuscular relaxation with vecuronium 0.1 mg kg -1 . Propofol was administered to all subjects by target-controlled infusion (Diprifusor; TERUMO, TE-371TM, Tokyo, Japan) to achieve a propofol concentration of 6.0 mg mL -1 at intubation. The patient was asked to raise the hand repeatedly and induction of anesthesia was deˆned as theˆrst lack of response to this command. At this point the total dose of propofol administered was noted from the pump display.
Statistical analysis: Data are expressed as mean± SD. DiŠerences between propofol concentrations and CO before and after the administration of atropine were analyzed using a paired t-test. Value of pº0.05 were considered statistically signiˆcant.
Study 2 (During continuous infusion)
Subjects: After Institutional approval, informed consent was obtained from 15 patients scheduled to undergo open abdominal surgery (9 men and 6 women; age range, 20-60 years; weight range, 40-75 kg). All patients were classiˆed as American Society of Anesthesiologists (ASA) I-II, and individuals with severe hepatic or renal insu‹ciency, coronary artery disease, signiˆcant hemodynamic instability, or known allergy to eggs or propofol were excluded from the study.
Sampling procedure: Before induction of anesthesia, routine monitoring was established, including pulse oximetry, ECG and non-invasive blood pressure. An intravenous catheter was placed in an antecubital vein for infusion of anesthetics and for ‰uid replacement. Anesthesia induction was carried out with propofol and neuromuscular relaxation with vecuronium 0.1 mg kg -1 , and was maintained with 60z nitrous oxide, 1-2z sevo‰urane in oxygen and continuous infusion of propofol. Propofol was administered to all subjects by target-controlled infusion (Diprifusor; TERUMO, TE-371TM, Tokyo, Japan) to achieve a propofol concentration of 6.0 mg mL -1 at intubation and 2.0 mg mL
after intubation throughout the study. A double lumen intravenous catheter was inserted into an internal jugular vein for injection of indocyanine green as an indicator for CO. A cannula was placed in the left radial artery for invasive blood pressure monitoring and blood sampling. Sevo‰urane was kept constant at 2z throughout the study. After predicted propofol concentration at 2.0 mg mL -1 was achieved and hemodynamic stability were established (±20z of pre-operative heart rate and blood pressure), injection of 20 mg indocyanine green was performed two times for the measurement of CO (thirty min of time-interval). At the same time, blood samples were also collected from a cannula inserted in the radial artery for measurement of blood propofol concentration. Then 0.01 mg kg -1 of atropine was administered intravenously to the patients. Thirty min after the administration of atropine, 20 mg of indocyanine green was again injected for the measurement of CO, and blood sample for the analysis of propofol concentration were collected again.
Analytical procedure: The dilution curve of indocyanine green was simultaneously recorded at the nasal wing using a specially designed optimal sensor that sandwiched the nasal wing between the light-emitting diodes and a photodiode measuring the intensity of the light transmitted through the nasal wing. CO was measured by the pulse dye densitometer (R470; Nihonkohden, Tokyo, Japan). 10) Propofol concentrations in whole blood were measured using high performance liquid chromatography (HPLC) as we reported previously. [1] [2] [3] [4] [5] Brie‰y, each sample (0.1-0.5 mL) with internal standard (thymol in methanol: 20 mL, 5 mg mL -1 ) was buŠered with 1 mL of 0.1 M phosphate buŠer (pH 7.4) and extracted using 5 mL of n-hexane. After centrifugation, 30 mL of tetran-butyl-ammonium hydroxide (TBAH) solution (0.5 M TBAH:methanol:2-propanol＝0.75:2.27:37.0) was added to 4 mL of the organic phase, and the solution was evaporated to dryness. The residue was re-dissolved in methanol (200 mL), and an aliquot (10 mL) was injected into a HPLC system (Waters 2690, Waters, U.S.A.). The column (WAT054275, 5 mm ODS, 4.6× 250 mm ID, Waters, U.S.A) was maintained at 309 C. The mobile phase comprising methanol-water (84:16, v W v) was pumped at a ‰ow rate of 1.0 mL min -1 . Propofol and thymol were detected using a ‰uorescence detector (Waters 474, Waters, U.S.A, excitation: 276 nm, emission: 297 nm). The limit of quantitation was 4 ngW mL and the reproducibility of the measurement was conˆrmed with a coe‹cient of variation of 3.3z, 2.1z and 0.6z at 10 ng W mL, 20 ng W mL and 50 ng W mL, respectively.
Statistical analysis: Data are expressed as mean± SD. Analysis of variance for repeated measurements was used to detect signiˆcant changes. When signiˆcance was found, the ScheŠe test was used as a post hoc comparison procedure. A p valueº0.05 was considered statistically signiˆcant. The spearman correlation coe‹cient for non-parametric data was used.
Results
Study 1
There were no signiˆcant diŠerences of age, sex, weight and height between each group ( Table 1) . Changes in blood pressure and heart rate are presented in Table 2 . The propofol dose for each group was 2.22±0.21 mg kg -1 for control group and 2.45±0.28 mg kg -1 for atropine group, respectively. There was a signiˆcant diŠerence between each group (p＝0.014). Atropine predosing increased the induction doses of propofol.
Study 2
Changes in blood pressure and heart rate are presented in Table 3 . No patients suŠered from hypotension that required the administration of catecholamine infusion (deˆned as systolic blood pressureº80 mmHg). During the study period, the amount of blood loss was less than 50 mL and lactated Ringer's solution 2 mL kg -1 was administered. After the administration of atropine, CO was signiˆcantly increased from 4.28±0.83 l min -1 to 5.76±1.55 l min -1 (pº0.0001). Propofol concentration was signiˆcantly decreased from 2.12±0.28 mg mL -1 to 1.69±0.27 mg mL -1 (pº0.0001) (Fig. 1) . The relationship between CO and propofol concentrations were shown in Fig. 2 . There was a signiˆcant correlation between them (n＝30, R 2 ＝0.3205).
Discussion
The present study demonstrated that propofol requirements for the induction of anesthesia was increased and propofol concentrations were decreased during constant infusion by the administration of atropine.
The induction dose of propofol was in‰uenced by many factors. It has been reported that age, 11) lean body mass 12) and degree of anxiety 13) aŠected the anesthetic requirement of propofol. In addition to these factors, CO is the determinant of propofol induction of anesthesia dose. 14) Upton et al. reported that the initial arterial concentration of propofol after short infusion was inversely related to CO in sheep 6) and Wilson et al. reported that predosing with esmolol reduced the propofol requirements for induction of anesthesia by 25z. 9) In the study 1, we found that propofol requirements for the induction of anesthesia was increased by predosing of atropine.
Myburgh et al. and Kurita et al. reported inverse relationship between CO and propofol concentration during constant rate infusions of propofol in ovine and in swine, respectively. 7, 8) Therefore, we compared propofol concentrations before and after the administration of atropine during constant rate infusion in the study 2. Before the administration, propofol concentrations were well achieved to predicted concentrations. After the administration of atropine, propofol concentrations were decreased with the increase of CO (Fig. 1) . There was a signiˆcant correlation between them (Fig. 2) . We demonstrated that propofol concentrations became lower following the administration of atropine.
This phenomenon can be explained by two mechanisms. First is the direct indicator dilution eŠect between venous injection site and arterial blood. Intravenous infusion is made into the entire CO by the time the heart and pulmonary artery are reached. Aˆxed dose added to a higher CO results in less drug per unit blood volume, and therefore lower concentrations. Indeed, the contribution ofˆrst pass dilution eŠect to steady state arterial concentration will simply be the drug clearance over the CO. This eŠect is therefore most signiˆcant for drugs with high clearance. 15) Secondly, higher CO implies higher blood ‰ows to the organs of drug elimination and distribution, increasing the rate of clearance and distribution and resulting in lower concentrations. Although the current study was performed via target-controlled infusion (TCI) system and we could not calculate the pharmacokinetic parameters, propofol pharmacokinetics is thus considered to be greatly in‰uenced by CO, as propofol is a high clearance drug.
The data in the study 1 was attributed principally to theˆrst mechanism and was considered of most importance after intravenous bolus injection of propofol, as used for the induction of anesthesia. The induction dose is dependent on both initial propofol concentration and cerebral blood ‰ow. However, due to an auto-regulation system, cerebral blood ‰ow remains reasonably stable within a mean blood pressure of 50-150 mmHg. 16) It is considered that there was no signiˆcant diŠerence in the cerebral blood ‰ow between the control and atropine groups. It would appear that the induction dose was dependent on initial propofol concentration rather than cerebral blood ‰ow. The data in the study 2 imply that changes in CO could alter the concentrations of propofol during constant rate infusion by both thê rst and second mechanisms. In summary, propofol dose requirements for the induction of anesthesia were increased and propofol concentrations were decreased during constant infusion by the administration of atropine. The possibility of inadequate anesthetic depth following the administration of atropine is suggested.
